Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
41 |
1672 |
1.459e-25 |
6.787e-22 |
2 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
34 |
1142 |
2.846e-23 |
6.622e-20 |
3 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
35 |
1395 |
1.371e-21 |
2.127e-18 |
4 |
REGULATION OF CELL PROLIFERATION |
35 |
1496 |
1.334e-20 |
1.552e-17 |
5 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
28 |
823 |
2.144e-20 |
1.996e-17 |
6 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
26 |
689 |
5.438e-20 |
4.217e-17 |
7 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
28 |
1021 |
6.267e-18 |
4.166e-15 |
8 |
REGULATION OF CELL DIFFERENTIATION |
32 |
1492 |
1.549e-17 |
8.959e-15 |
9 |
RESPONSE TO GROWTH FACTOR |
21 |
475 |
1.733e-17 |
8.959e-15 |
10 |
REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
18 |
337 |
1.81e-16 |
7.656e-14 |
11 |
TISSUE MORPHOGENESIS |
21 |
533 |
1.766e-16 |
7.656e-14 |
12 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
34 |
1929 |
3.845e-16 |
1.491e-13 |
13 |
POSITIVE REGULATION OF CELL PROLIFERATION |
24 |
814 |
5.467e-16 |
1.957e-13 |
14 |
REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
11 |
67 |
7.619e-16 |
2.532e-13 |
15 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
23 |
771 |
2.003e-15 |
6.215e-13 |
16 |
POSITIVE REGULATION OF CELL COMMUNICATION |
30 |
1532 |
2.803e-15 |
8.152e-13 |
17 |
MORPHOGENESIS OF AN EPITHELIUM |
18 |
400 |
3.606e-15 |
9.871e-13 |
18 |
POSITIVE REGULATION OF CELL DEVELOPMENT |
19 |
472 |
4.178e-15 |
1.08e-12 |
19 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
29 |
1492 |
1.192e-14 |
2.676e-12 |
20 |
REGULATION OF CELL DEVELOPMENT |
23 |
836 |
1.126e-14 |
2.676e-12 |
21 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
30 |
1618 |
1.208e-14 |
2.676e-12 |
22 |
POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
26 |
1152 |
1.407e-14 |
2.976e-12 |
23 |
POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
13 |
162 |
2.25e-14 |
4.551e-12 |
24 |
TUBE MORPHOGENESIS |
16 |
323 |
3.395e-14 |
6.582e-12 |
25 |
TUBE DEVELOPMENT |
19 |
552 |
7.001e-14 |
1.253e-11 |
26 |
REGULATION OF CELL MORPHOGENESIS |
19 |
552 |
7.001e-14 |
1.253e-11 |
27 |
REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
14 |
229 |
9.089e-14 |
1.566e-11 |
28 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
24 |
1036 |
1.114e-13 |
1.787e-11 |
29 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
24 |
1036 |
1.114e-13 |
1.787e-11 |
30 |
POSITIVE REGULATION OF LOCOMOTION |
17 |
420 |
1.312e-13 |
2.035e-11 |
31 |
EPITHELIUM DEVELOPMENT |
23 |
945 |
1.489e-13 |
2.235e-11 |
32 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
29 |
1656 |
1.731e-13 |
2.517e-11 |
33 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
23 |
957 |
1.938e-13 |
2.733e-11 |
34 |
RESPONSE TO EXTERNAL STIMULUS |
30 |
1821 |
2.728e-13 |
3.733e-11 |
35 |
POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
22 |
876 |
3.07e-13 |
3.968e-11 |
36 |
REGULATION OF STEM CELL DIFFERENTIATION |
11 |
113 |
3.023e-13 |
3.968e-11 |
37 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
30 |
1848 |
4.003e-13 |
4.657e-11 |
38 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
29 |
1710 |
3.906e-13 |
4.657e-11 |
39 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
21 |
788 |
3.857e-13 |
4.657e-11 |
40 |
CIRCULATORY SYSTEM DEVELOPMENT |
21 |
788 |
3.857e-13 |
4.657e-11 |
41 |
LOCOMOTION |
24 |
1114 |
5.346e-13 |
6.067e-11 |
42 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
24 |
1135 |
7.981e-13 |
8.842e-11 |
43 |
TISSUE DEVELOPMENT |
27 |
1518 |
1.136e-12 |
1.23e-10 |
44 |
ORGAN MORPHOGENESIS |
21 |
841 |
1.343e-12 |
1.42e-10 |
45 |
TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY |
17 |
498 |
2.027e-12 |
2.096e-10 |
46 |
UROGENITAL SYSTEM DEVELOPMENT |
14 |
299 |
3.447e-12 |
3.487e-10 |
47 |
EMBRYO DEVELOPMENT |
21 |
894 |
4.291e-12 |
4.248e-10 |
48 |
EMBRYONIC MORPHOGENESIS |
17 |
539 |
7.115e-12 |
6.897e-10 |
49 |
NEUROGENESIS |
25 |
1402 |
9.871e-12 |
9.33e-10 |
50 |
VASCULATURE DEVELOPMENT |
16 |
469 |
1.003e-11 |
9.33e-10 |
51 |
MORPHOGENESIS OF A BRANCHING STRUCTURE |
11 |
167 |
2.247e-11 |
2.05e-09 |
52 |
REGULATION OF CELL DEATH |
25 |
1472 |
2.837e-11 |
2.538e-09 |
53 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
16 |
513 |
3.817e-11 |
3.351e-09 |
54 |
POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
15 |
437 |
4.447e-11 |
3.762e-09 |
55 |
POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT |
12 |
232 |
4.399e-11 |
3.762e-09 |
56 |
BLOOD VESSEL MORPHOGENESIS |
14 |
364 |
4.776e-11 |
3.968e-09 |
57 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
27 |
1791 |
5.319e-11 |
4.342e-09 |
58 |
POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION |
13 |
303 |
6.552e-11 |
5.256e-09 |
59 |
MOVEMENT OF CELL OR SUBCELLULAR COMPONENT |
23 |
1275 |
6.824e-11 |
5.382e-09 |
60 |
PEPTIDYL TYROSINE MODIFICATION |
11 |
186 |
7.211e-11 |
5.592e-09 |
61 |
CELL MOTILITY |
19 |
835 |
9.595e-11 |
7.178e-09 |
62 |
LOCALIZATION OF CELL |
19 |
835 |
9.595e-11 |
7.178e-09 |
63 |
CELL DEVELOPMENT |
24 |
1426 |
9.719e-11 |
7.178e-09 |
64 |
POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION |
9 |
103 |
1.319e-10 |
9.588e-09 |
65 |
REGULATION OF MAPK CASCADE |
17 |
660 |
1.68e-10 |
1.203e-08 |
66 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
20 |
983 |
2.013e-10 |
1.419e-08 |
67 |
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
10 |
154 |
2.238e-10 |
1.554e-08 |
68 |
PATTERN SPECIFICATION PROCESS |
14 |
418 |
2.944e-10 |
2.014e-08 |
69 |
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS |
20 |
1008 |
3.129e-10 |
2.11e-08 |
70 |
POSITIVE REGULATION OF CATALYTIC ACTIVITY |
24 |
1518 |
3.499e-10 |
2.326e-08 |
71 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
18 |
801 |
4.027e-10 |
2.639e-08 |
72 |
REGULATION OF EPITHELIAL CELL MIGRATION |
10 |
166 |
4.681e-10 |
3.009e-08 |
73 |
REGULATION OF EPITHELIAL CELL PROLIFERATION |
12 |
285 |
4.72e-10 |
3.009e-08 |
74 |
PROTEIN PHOSPHORYLATION |
19 |
944 |
7.564e-10 |
4.696e-08 |
75 |
REGULATION OF CELL ADHESION |
16 |
629 |
7.569e-10 |
4.696e-08 |
76 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
16 |
643 |
1.04e-09 |
6.368e-08 |
77 |
POSITIVE REGULATION OF NEURON DIFFERENTIATION |
12 |
306 |
1.061e-09 |
6.41e-08 |
78 |
TAXIS |
14 |
464 |
1.141e-09 |
6.807e-08 |
79 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
17 |
750 |
1.185e-09 |
6.98e-08 |
80 |
REGIONALIZATION |
12 |
311 |
1.275e-09 |
7.415e-08 |
81 |
REGULATION OF CELL PROJECTION ORGANIZATION |
15 |
558 |
1.312e-09 |
7.534e-08 |
82 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
22 |
1360 |
1.557e-09 |
8.832e-08 |
83 |
NEURON DIFFERENTIATION |
18 |
874 |
1.615e-09 |
9.056e-08 |
84 |
CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS |
5 |
15 |
1.645e-09 |
9.112e-08 |
85 |
TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
10 |
190 |
1.747e-09 |
9.561e-08 |
86 |
POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
6 |
34 |
2.378e-09 |
1.287e-07 |
87 |
REPRODUCTIVE SYSTEM DEVELOPMENT |
13 |
408 |
2.495e-09 |
1.319e-07 |
88 |
REGULATION OF NEURON PROJECTION DEVELOPMENT |
13 |
408 |
2.495e-09 |
1.319e-07 |
89 |
CELLULAR COMPONENT MORPHOGENESIS |
18 |
900 |
2.565e-09 |
1.341e-07 |
90 |
POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
8 |
100 |
3.023e-09 |
1.563e-07 |
91 |
NEURON PROJECTION GUIDANCE |
10 |
205 |
3.641e-09 |
1.862e-07 |
92 |
REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
10 |
207 |
3.998e-09 |
2.022e-07 |
93 |
RESPONSE TO ENDOGENOUS STIMULUS |
22 |
1450 |
5.099e-09 |
2.551e-07 |
94 |
ANGIOGENESIS |
11 |
293 |
8.794e-09 |
4.353e-07 |
95 |
AMINOGLYCAN METABOLIC PROCESS |
9 |
166 |
9.264e-09 |
4.538e-07 |
96 |
CEREBRAL CORTEX CELL MIGRATION |
6 |
43 |
1.05e-08 |
5.092e-07 |
97 |
REGULATION OF NEURON DIFFERENTIATION |
14 |
554 |
1.096e-08 |
5.256e-07 |
98 |
NEGATIVE REGULATION OF CELL DEATH |
17 |
872 |
1.13e-08 |
5.309e-07 |
99 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
17 |
872 |
1.13e-08 |
5.309e-07 |
100 |
RESPONSE TO OXYGEN CONTAINING COMPOUND |
21 |
1381 |
1.211e-08 |
5.635e-07 |
101 |
POSITIVE REGULATION OF MAPK CASCADE |
13 |
470 |
1.351e-08 |
6.225e-07 |
102 |
ACTIVIN RECEPTOR SIGNALING PATHWAY |
5 |
22 |
1.414e-08 |
6.451e-07 |
103 |
RESPONSE TO LIPID |
17 |
888 |
1.477e-08 |
6.672e-07 |
104 |
REGULATION OF KINASE ACTIVITY |
16 |
776 |
1.508e-08 |
6.745e-07 |
105 |
KIDNEY EPITHELIUM DEVELOPMENT |
8 |
125 |
1.777e-08 |
7.875e-07 |
106 |
POSITIVE REGULATION OF KINASE ACTIVITY |
13 |
482 |
1.82e-08 |
7.99e-07 |
107 |
POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION |
6 |
48 |
2.084e-08 |
9.064e-07 |
108 |
BLOOD VESSEL ENDOTHELIAL CELL MIGRATION |
5 |
24 |
2.27e-08 |
9.688e-07 |
109 |
RESPONSE TO STEROL |
5 |
24 |
2.27e-08 |
9.688e-07 |
110 |
SENSORY ORGAN DEVELOPMENT |
13 |
493 |
2.374e-08 |
9.953e-07 |
111 |
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION |
12 |
404 |
2.374e-08 |
9.953e-07 |
112 |
EMBRYONIC ORGAN DEVELOPMENT |
12 |
406 |
2.507e-08 |
1.041e-06 |
113 |
BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE |
8 |
131 |
2.568e-08 |
1.058e-06 |
114 |
EYE DEVELOPMENT |
11 |
326 |
2.639e-08 |
1.077e-06 |
115 |
POSITIVE REGULATION OF STEM CELL DIFFERENTIATION |
6 |
50 |
2.684e-08 |
1.086e-06 |
116 |
REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
17 |
926 |
2.73e-08 |
1.095e-06 |
117 |
GROWTH |
12 |
410 |
2.792e-08 |
1.111e-06 |
118 |
HEAD DEVELOPMENT |
15 |
709 |
3.258e-08 |
1.285e-06 |
119 |
REGULATION OF RESPONSE TO STRESS |
21 |
1468 |
3.504e-08 |
1.37e-06 |
120 |
AXIS SPECIFICATION |
7 |
90 |
3.774e-08 |
1.428e-06 |
121 |
REGULATION OF TRANSFERASE ACTIVITY |
17 |
946 |
3.728e-08 |
1.428e-06 |
122 |
ENDOTHELIUM DEVELOPMENT |
7 |
90 |
3.774e-08 |
1.428e-06 |
123 |
MESONEPHROS DEVELOPMENT |
7 |
90 |
3.774e-08 |
1.428e-06 |
124 |
NEGATIVE REGULATION OF LOCOMOTION |
10 |
263 |
3.911e-08 |
1.467e-06 |
125 |
POSITIVE REGULATION OF TRANSFERASE ACTIVITY |
14 |
616 |
4.133e-08 |
1.538e-06 |
126 |
SUBSTRATE DEPENDENT CELL MIGRATION |
5 |
27 |
4.274e-08 |
1.578e-06 |
127 |
REGULATION OF TRANSPORT |
23 |
1804 |
5.448e-08 |
1.981e-06 |
128 |
PHOSPHORYLATION |
19 |
1228 |
5.448e-08 |
1.981e-06 |
129 |
ENDOTHELIAL CELL MIGRATION |
6 |
57 |
6.006e-08 |
2.166e-06 |
130 |
EMBRYONIC PATTERN SPECIFICATION |
6 |
58 |
6.68e-08 |
2.391e-06 |
131 |
REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION |
6 |
60 |
8.215e-08 |
2.918e-06 |
132 |
CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION |
11 |
368 |
9.047e-08 |
3.189e-06 |
133 |
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING |
13 |
554 |
9.263e-08 |
3.241e-06 |
134 |
FOREBRAIN CELL MIGRATION |
6 |
62 |
1.003e-07 |
3.483e-06 |
135 |
CEREBRAL CORTEX DEVELOPMENT |
7 |
105 |
1.101e-07 |
3.795e-06 |
136 |
RESPONSE TO WOUNDING |
13 |
563 |
1.116e-07 |
3.818e-06 |
137 |
HEART DEVELOPMENT |
12 |
466 |
1.128e-07 |
3.831e-06 |
138 |
EMBRYONIC AXIS SPECIFICATION |
5 |
33 |
1.235e-07 |
4.165e-06 |
139 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
18 |
1192 |
1.902e-07 |
6.366e-06 |
140 |
HOMEOSTATIC PROCESS |
19 |
1337 |
2.065e-07 |
6.862e-06 |
141 |
NEURON PROJECTION MORPHOGENESIS |
11 |
402 |
2.197e-07 |
7.25e-06 |
142 |
SKIN EPIDERMIS DEVELOPMENT |
6 |
71 |
2.277e-07 |
7.461e-06 |
143 |
REGULATION OF MAP KINASE ACTIVITY |
10 |
319 |
2.365e-07 |
7.694e-06 |
144 |
CELLULAR RESPONSE TO ACID CHEMICAL |
8 |
175 |
2.424e-07 |
7.78e-06 |
145 |
DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION |
13 |
602 |
2.408e-07 |
7.78e-06 |
146 |
ENDOTHELIAL CELL DIFFERENTIATION |
6 |
72 |
2.477e-07 |
7.894e-06 |
147 |
POSITIVE REGULATION OF CELL DEATH |
13 |
605 |
2.548e-07 |
8.066e-06 |
148 |
RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE |
4 |
16 |
2.875e-07 |
9.04e-06 |
149 |
WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY |
5 |
39 |
2.946e-07 |
9.201e-06 |
150 |
PEPTIDYL AMINO ACID MODIFICATION |
15 |
841 |
2.986e-07 |
9.262e-06 |
151 |
REGULATION OF CHEMOTAXIS |
8 |
180 |
3.007e-07 |
9.267e-06 |
152 |
DEVELOPMENTAL GROWTH |
10 |
333 |
3.51e-07 |
1.075e-05 |
153 |
SEX DIFFERENTIATION |
9 |
266 |
5.254e-07 |
1.598e-05 |
154 |
ANTERIOR POSTERIOR PATTERN SPECIFICATION |
8 |
194 |
5.319e-07 |
1.607e-05 |
155 |
HAIR CYCLE |
6 |
83 |
5.798e-07 |
1.718e-05 |
156 |
POSITIVE REGULATION OF GENE EXPRESSION |
21 |
1733 |
5.773e-07 |
1.718e-05 |
157 |
MOLTING CYCLE |
6 |
83 |
5.798e-07 |
1.718e-05 |
158 |
NEURON PROJECTION DEVELOPMENT |
12 |
545 |
6.017e-07 |
1.772e-05 |
159 |
SPROUTING ANGIOGENESIS |
5 |
45 |
6.147e-07 |
1.799e-05 |
160 |
TISSUE MIGRATION |
6 |
84 |
6.226e-07 |
1.81e-05 |
161 |
PALATE DEVELOPMENT |
6 |
85 |
6.679e-07 |
1.93e-05 |
162 |
CELL PROJECTION ORGANIZATION |
15 |
902 |
7.254e-07 |
2.083e-05 |
163 |
SKELETAL SYSTEM DEVELOPMENT |
11 |
455 |
7.487e-07 |
2.135e-05 |
164 |
RESPONSE TO ALCOHOL |
10 |
362 |
7.524e-07 |
2.135e-05 |
165 |
DORSAL VENTRAL AXIS SPECIFICATION |
4 |
20 |
7.57e-07 |
2.135e-05 |
166 |
CELLULAR RESPONSE TO LIPID |
11 |
457 |
7.816e-07 |
2.18e-05 |
167 |
EMBRYONIC ORGAN MORPHOGENESIS |
9 |
279 |
7.824e-07 |
2.18e-05 |
168 |
CELL PROLIFERATION |
13 |
672 |
8.358e-07 |
2.315e-05 |
169 |
DIGESTIVE TRACT MORPHOGENESIS |
5 |
48 |
8.542e-07 |
2.352e-05 |
170 |
RESPONSE TO TRANSFORMING GROWTH FACTOR BETA |
7 |
144 |
9.493e-07 |
2.598e-05 |
171 |
CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND |
14 |
799 |
9.734e-07 |
2.649e-05 |
172 |
WOUND HEALING |
11 |
470 |
1.028e-06 |
2.782e-05 |
173 |
REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
8 |
213 |
1.077e-06 |
2.897e-05 |
174 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
21 |
1805 |
1.124e-06 |
3.007e-05 |
175 |
REGULATION OF CELLULAR RESPONSE TO STRESS |
13 |
691 |
1.141e-06 |
3.035e-05 |
176 |
REGULATION OF CELL CELL ADHESION |
10 |
380 |
1.167e-06 |
3.086e-05 |
177 |
RESPONSE TO BMP |
6 |
94 |
1.212e-06 |
3.168e-05 |
178 |
CELLULAR RESPONSE TO BMP STIMULUS |
6 |
94 |
1.212e-06 |
3.168e-05 |
179 |
PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS |
22 |
1977 |
1.219e-06 |
3.168e-05 |
180 |
CANONICAL WNT SIGNALING PATHWAY |
6 |
95 |
1.29e-06 |
3.334e-05 |
181 |
REGULATION OF CELL ACTIVATION |
11 |
484 |
1.369e-06 |
3.519e-05 |
182 |
PALLIUM DEVELOPMENT |
7 |
153 |
1.426e-06 |
3.647e-05 |
183 |
GLAND MORPHOGENESIS |
6 |
97 |
1.458e-06 |
3.707e-05 |
184 |
GASTRULATION |
7 |
155 |
1.556e-06 |
3.935e-05 |
185 |
GLAND DEVELOPMENT |
10 |
395 |
1.654e-06 |
4.159e-05 |
186 |
REGULATION OF HOMOTYPIC CELL CELL ADHESION |
9 |
307 |
1.727e-06 |
4.32e-05 |
187 |
IN UTERO EMBRYONIC DEVELOPMENT |
9 |
311 |
1.921e-06 |
4.779e-05 |
188 |
REGULATION OF VASCULATURE DEVELOPMENT |
8 |
233 |
2.108e-06 |
5.217e-05 |
189 |
RESPONSE TO ACID CHEMICAL |
9 |
319 |
2.366e-06 |
5.824e-05 |
190 |
POSITIVE REGULATION OF GROWTH |
8 |
238 |
2.469e-06 |
6.046e-05 |
191 |
REGULATION OF CELLULAR LOCALIZATION |
17 |
1277 |
2.545e-06 |
6.201e-05 |
192 |
RESPONSE TO CARBOHYDRATE |
7 |
168 |
2.662e-06 |
6.451e-05 |
193 |
REGULATION OF ORGAN MORPHOGENESIS |
8 |
242 |
2.794e-06 |
6.736e-05 |
194 |
CELL PART MORPHOGENESIS |
12 |
633 |
2.866e-06 |
6.84e-05 |
195 |
REGULATION OF GROWTH |
12 |
633 |
2.866e-06 |
6.84e-05 |
196 |
REGULATION OF ENDOTHELIAL CELL MIGRATION |
6 |
114 |
3.747e-06 |
8.896e-05 |
197 |
BIOLOGICAL ADHESION |
15 |
1032 |
3.847e-06 |
9.086e-05 |
198 |
CELLULAR RESPONSE TO ALCOHOL |
6 |
115 |
3.942e-06 |
9.265e-05 |
199 |
FEMALE SEX DIFFERENTIATION |
6 |
116 |
4.146e-06 |
9.693e-05 |
200 |
REGULATION OF HYDROLASE ACTIVITY |
17 |
1327 |
4.272e-06 |
9.939e-05 |
201 |
POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION |
5 |
67 |
4.565e-06 |
0.0001057 |
202 |
REGULATION OF CELL JUNCTION ASSEMBLY |
5 |
68 |
4.914e-06 |
0.0001126 |
203 |
POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
5 |
68 |
4.914e-06 |
0.0001126 |
204 |
POSITIVE REGULATION OF CHEMOTAXIS |
6 |
120 |
5.045e-06 |
0.0001151 |
205 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
6 |
121 |
5.293e-06 |
0.0001201 |
206 |
CELL ACTIVATION |
11 |
568 |
6.356e-06 |
0.0001436 |
207 |
PROTEIN AUTOPHOSPHORYLATION |
7 |
192 |
6.427e-06 |
0.0001445 |
208 |
NEURON DEVELOPMENT |
12 |
687 |
6.611e-06 |
0.0001479 |
209 |
REGULATION OF WOUND HEALING |
6 |
126 |
6.686e-06 |
0.0001489 |
210 |
BRAIN MORPHOGENESIS |
4 |
34 |
6.972e-06 |
0.0001545 |
211 |
REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
9 |
365 |
7.061e-06 |
0.0001557 |
212 |
REGULATION OF PROTEIN LOCALIZATION |
14 |
950 |
7.289e-06 |
0.00016 |
213 |
VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY |
5 |
74 |
7.466e-06 |
0.0001631 |
214 |
POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS |
3 |
11 |
7.538e-06 |
0.0001638 |
215 |
REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
7 |
197 |
7.605e-06 |
0.0001638 |
216 |
RESPIRATORY SYSTEM DEVELOPMENT |
7 |
197 |
7.605e-06 |
0.0001638 |
217 |
REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
10 |
470 |
7.714e-06 |
0.0001654 |
218 |
REGULATION OF SECRETION |
12 |
699 |
7.875e-06 |
0.0001681 |
219 |
ARTERY DEVELOPMENT |
5 |
75 |
7.976e-06 |
0.0001695 |
220 |
SKELETAL SYSTEM MORPHOGENESIS |
7 |
201 |
8.672e-06 |
0.0001834 |
221 |
POSITIVE CHEMOTAXIS |
4 |
36 |
8.806e-06 |
0.0001854 |
222 |
POSITIVE REGULATION OF CELL ADHESION |
9 |
376 |
8.961e-06 |
0.0001878 |
223 |
POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE |
6 |
135 |
9.938e-06 |
0.0002074 |
224 |
REGULATION OF LEUKOCYTE PROLIFERATION |
7 |
206 |
1.018e-05 |
0.0002114 |
225 |
POSITIVE REGULATION OF MAP KINASE ACTIVITY |
7 |
207 |
1.05e-05 |
0.0002172 |
226 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
6 |
138 |
1.127e-05 |
0.000232 |
227 |
REGULATION OF JUN KINASE ACTIVITY |
5 |
81 |
1.164e-05 |
0.0002386 |
228 |
SKIN DEVELOPMENT |
7 |
211 |
1.19e-05 |
0.0002428 |
229 |
REGULATION OF PHOSPHOLIPASE C ACTIVITY |
4 |
39 |
1.22e-05 |
0.0002445 |
230 |
NON CANONICAL WNT SIGNALING PATHWAY |
6 |
140 |
1.224e-05 |
0.0002445 |
231 |
REGULATION OF CELL GROWTH |
9 |
391 |
1.225e-05 |
0.0002445 |
232 |
PEPTIDYL TYROSINE AUTOPHOSPHORYLATION |
4 |
39 |
1.22e-05 |
0.0002445 |
233 |
POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION |
4 |
39 |
1.22e-05 |
0.0002445 |
234 |
KIDNEY MORPHOGENESIS |
5 |
82 |
1.236e-05 |
0.0002458 |
235 |
GANGLION DEVELOPMENT |
3 |
13 |
1.3e-05 |
0.0002573 |
236 |
PROTEOGLYCAN METABOLIC PROCESS |
5 |
83 |
1.312e-05 |
0.0002575 |
237 |
POSITIVE REGULATION OF EXOCYTOSIS |
5 |
83 |
1.312e-05 |
0.0002575 |
238 |
DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS |
7 |
216 |
1.385e-05 |
0.0002707 |
239 |
REPRODUCTION |
16 |
1297 |
1.392e-05 |
0.0002709 |
240 |
VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY |
3 |
14 |
1.65e-05 |
0.0003187 |
241 |
POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS |
9 |
406 |
1.651e-05 |
0.0003187 |
242 |
DIGESTIVE SYSTEM DEVELOPMENT |
6 |
148 |
1.679e-05 |
0.0003215 |
243 |
POSITIVE REGULATION OF CELL GROWTH |
6 |
148 |
1.679e-05 |
0.0003215 |
244 |
OVULATION CYCLE PROCESS |
5 |
88 |
1.745e-05 |
0.0003328 |
245 |
POST EMBRYONIC DEVELOPMENT |
5 |
89 |
1.844e-05 |
0.0003502 |
246 |
IMMUNE SYSTEM PROCESS |
20 |
1984 |
1.895e-05 |
0.0003569 |
247 |
REGULATION OF RESPONSE TO WOUNDING |
9 |
413 |
1.89e-05 |
0.0003569 |
248 |
CELL FATE COMMITMENT |
7 |
227 |
1.908e-05 |
0.000358 |
249 |
MIDBRAIN DEVELOPMENT |
5 |
90 |
1.947e-05 |
0.0003638 |
250 |
TELENCEPHALON DEVELOPMENT |
7 |
228 |
1.963e-05 |
0.0003653 |
251 |
REGULATION OF CELLULAR COMPONENT BIOGENESIS |
12 |
767 |
1.99e-05 |
0.0003674 |
252 |
BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS |
4 |
44 |
1.985e-05 |
0.0003674 |
253 |
MULTICELLULAR ORGANISM REPRODUCTION |
12 |
768 |
2.016e-05 |
0.0003707 |
254 |
DORSAL VENTRAL PATTERN FORMATION |
5 |
91 |
2.054e-05 |
0.0003763 |
255 |
AMEBOIDAL TYPE CELL MIGRATION |
6 |
154 |
2.103e-05 |
0.0003838 |
256 |
POSITIVE REGULATION OF HYDROLASE ACTIVITY |
13 |
905 |
2.122e-05 |
0.0003857 |
257 |
EMBRYONIC CRANIAL SKELETON MORPHOGENESIS |
4 |
46 |
2.373e-05 |
0.0004297 |
258 |
NEGATIVE REGULATION OF GROWTH |
7 |
236 |
2.45e-05 |
0.0004418 |
259 |
REGULATION OF JNK CASCADE |
6 |
159 |
2.519e-05 |
0.0004526 |
260 |
TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
5 |
95 |
2.53e-05 |
0.0004528 |
261 |
POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION |
6 |
162 |
2.799e-05 |
0.000499 |
262 |
REGULATION OF ENDOTHELIAL CELL PROLIFERATION |
5 |
98 |
2.941e-05 |
0.0005223 |
263 |
POSITIVE REGULATION OF CELL CELL ADHESION |
7 |
243 |
2.953e-05 |
0.0005225 |
264 |
POSITIVE REGULATION OF TRANSPORT |
13 |
936 |
3.017e-05 |
0.0005317 |
265 |
REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS |
3 |
17 |
3.058e-05 |
0.0005369 |
266 |
REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
5 |
99 |
3.088e-05 |
0.0005382 |
267 |
REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
5 |
99 |
3.088e-05 |
0.0005382 |
268 |
NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS |
14 |
1087 |
3.292e-05 |
0.0005716 |
269 |
REGULATION OF ADHERENS JUNCTION ORGANIZATION |
4 |
50 |
3.313e-05 |
0.000573 |
270 |
REGULATION OF AXONOGENESIS |
6 |
168 |
3.434e-05 |
0.0005917 |
271 |
REGULATION OF CYTOKINE PRODUCTION |
10 |
563 |
3.642e-05 |
0.0006249 |
272 |
REGULATION OF IMMUNE SYSTEM PROCESS |
16 |
1403 |
3.653e-05 |
0.0006249 |
273 |
EPIDERMIS DEVELOPMENT |
7 |
253 |
3.818e-05 |
0.0006508 |
274 |
DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS |
5 |
104 |
3.915e-05 |
0.0006649 |
275 |
REGULATION OF CELL SUBSTRATE ADHESION |
6 |
173 |
4.047e-05 |
0.0006847 |
276 |
POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY |
4 |
53 |
4.177e-05 |
0.0007017 |
277 |
MESONEPHRIC TUBULE MORPHOGENESIS |
4 |
53 |
4.177e-05 |
0.0007017 |
278 |
GLYCOPROTEIN METABOLIC PROCESS |
8 |
353 |
4.308e-05 |
0.000721 |
279 |
AMINOGLYCAN BIOSYNTHETIC PROCESS |
5 |
107 |
4.488e-05 |
0.0007458 |
280 |
RESPONSE TO RETINOIC ACID |
5 |
107 |
4.488e-05 |
0.0007458 |
281 |
REGULATION OF VESICLE MEDIATED TRANSPORT |
9 |
462 |
4.539e-05 |
0.0007516 |
282 |
REGULATION OF OSSIFICATION |
6 |
178 |
4.745e-05 |
0.0007829 |
283 |
IMMUNE SYSTEM DEVELOPMENT |
10 |
582 |
4.817e-05 |
0.0007919 |
284 |
CRANIAL SKELETAL SYSTEM DEVELOPMENT |
4 |
55 |
4.839e-05 |
0.0007928 |
285 |
REGULATION OF ESTABLISHMENT OF PLANAR POLARITY |
5 |
110 |
5.123e-05 |
0.0008335 |
286 |
NEURON MIGRATION |
5 |
110 |
5.123e-05 |
0.0008335 |
287 |
SMAD PROTEIN SIGNAL TRANSDUCTION |
4 |
56 |
5.197e-05 |
0.0008396 |
288 |
EPITHELIAL TO MESENCHYMAL TRANSITION |
4 |
56 |
5.197e-05 |
0.0008396 |
289 |
REGULATION OF OSTEOBLAST DIFFERENTIATION |
5 |
112 |
5.584e-05 |
0.000899 |
290 |
OVULATION CYCLE |
5 |
113 |
5.826e-05 |
0.0009347 |
291 |
REGULATION OF HORMONE LEVELS |
9 |
478 |
5.902e-05 |
0.0009431 |
292 |
SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT |
3 |
21 |
5.919e-05 |
0.0009431 |
293 |
REGULATION OF EXOCYTOSIS |
6 |
186 |
6.059e-05 |
0.0009616 |
294 |
REGULATION OF EMBRYONIC DEVELOPMENT |
5 |
114 |
6.076e-05 |
0.0009616 |
295 |
NEPHRON DEVELOPMENT |
5 |
115 |
6.334e-05 |
0.0009957 |
296 |
NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
7 |
274 |
6.32e-05 |
0.0009957 |
297 |
VASCULOGENESIS |
4 |
59 |
6.386e-05 |
0.0009974 |
298 |
PROTEIN LOCALIZATION |
18 |
1805 |
6.388e-05 |
0.0009974 |
299 |
PROTEIN LOCALIZATION TO CELL SURFACE |
3 |
22 |
6.835e-05 |
0.00106 |
300 |
MESENCHYME DEVELOPMENT |
6 |
190 |
6.818e-05 |
0.00106 |
301 |
NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
5 |
117 |
6.876e-05 |
0.001063 |
302 |
ACTIVATION OF PROTEIN KINASE ACTIVITY |
7 |
279 |
7.08e-05 |
0.001091 |
303 |
POSITIVE REGULATION OF JUN KINASE ACTIVITY |
4 |
63 |
8.267e-05 |
0.00127 |
304 |
EMBRYONIC SKELETAL SYSTEM DEVELOPMENT |
5 |
122 |
8.388e-05 |
0.001284 |
305 |
REGULATION OF DEVELOPMENTAL GROWTH |
7 |
289 |
8.825e-05 |
0.001333 |
306 |
REGULATION OF PHOSPHOLIPASE ACTIVITY |
4 |
64 |
8.794e-05 |
0.001333 |
307 |
POSITIVE REGULATION OF DENDRITE DEVELOPMENT |
4 |
64 |
8.794e-05 |
0.001333 |
308 |
POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY |
7 |
289 |
8.825e-05 |
0.001333 |
309 |
CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS |
3 |
24 |
8.936e-05 |
0.001346 |
310 |
CELLULAR RESPONSE TO RETINOIC ACID |
4 |
65 |
9.345e-05 |
0.001403 |
311 |
SOMATIC STEM CELL POPULATION MAINTENANCE |
4 |
66 |
9.92e-05 |
0.001479 |
312 |
POSITIVE REGULATION OF LIPASE ACTIVITY |
4 |
66 |
9.92e-05 |
0.001479 |
313 |
CELL CELL SIGNALING |
11 |
767 |
9.985e-05 |
0.001484 |
314 |
EPITHELIAL CELL APOPTOTIC PROCESS |
3 |
25 |
0.0001013 |
0.001501 |
315 |
POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS |
7 |
296 |
0.0001024 |
0.001513 |
316 |
TUBE FORMATION |
5 |
129 |
0.0001092 |
0.001608 |
317 |
RESPONSE TO ORGANIC CYCLIC COMPOUND |
12 |
917 |
0.0001117 |
0.001629 |
318 |
ORGAN GROWTH |
4 |
68 |
0.0001115 |
0.001629 |
319 |
AMINOGLYCAN CATABOLIC PROCESS |
4 |
68 |
0.0001115 |
0.001629 |
320 |
POSITIVE REGULATION OF AXONOGENESIS |
4 |
69 |
0.000118 |
0.001716 |
321 |
MAINTENANCE OF CELL NUMBER |
5 |
132 |
0.0001217 |
0.001764 |
322 |
HEART MORPHOGENESIS |
6 |
212 |
0.0001246 |
0.001798 |
323 |
CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT |
4 |
70 |
0.0001248 |
0.001798 |
324 |
MOTOR NEURON AXON GUIDANCE |
3 |
27 |
0.0001281 |
0.00184 |
325 |
MORPHOGENESIS OF EMBRYONIC EPITHELIUM |
5 |
134 |
0.0001306 |
0.001864 |
326 |
MESENCHYMAL CELL DIFFERENTIATION |
5 |
134 |
0.0001306 |
0.001864 |
327 |
POSITIVE REGULATION OF CELL ACTIVATION |
7 |
311 |
0.0001391 |
0.00198 |
328 |
GASTRULATION WITH MOUTH FORMING SECOND |
3 |
28 |
0.0001431 |
0.002024 |
329 |
HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS |
3 |
28 |
0.0001431 |
0.002024 |
330 |
PANCREAS DEVELOPMENT |
4 |
73 |
0.000147 |
0.002072 |
331 |
RESPONSE TO DRUG |
8 |
431 |
0.0001722 |
0.00242 |
332 |
REGULATION OF DENDRITIC SPINE MORPHOGENESIS |
3 |
30 |
0.0001765 |
0.002466 |
333 |
CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS |
3 |
30 |
0.0001765 |
0.002466 |
334 |
REGULATION OF BMP SIGNALING PATHWAY |
4 |
77 |
0.0001807 |
0.00251 |
335 |
DEVELOPMENTAL CELL GROWTH |
4 |
77 |
0.0001807 |
0.00251 |
336 |
NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION |
10 |
684 |
0.0001822 |
0.002524 |
337 |
POSITIVE REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
6 |
228 |
0.000185 |
0.002555 |
338 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
17 |
1784 |
0.0001862 |
0.002563 |
339 |
HORMONE TRANSPORT |
4 |
78 |
0.00019 |
0.0026 |
340 |
RENAL TUBULE DEVELOPMENT |
4 |
78 |
0.00019 |
0.0026 |
341 |
CARTILAGE DEVELOPMENT |
5 |
147 |
0.0002014 |
0.002732 |
342 |
REGULATION OF T CELL PROLIFERATION |
5 |
147 |
0.0002014 |
0.002732 |
343 |
RESPONSE TO EXTRACELLULAR STIMULUS |
8 |
441 |
0.0002012 |
0.002732 |
344 |
REGULATION OF LEUKOCYTE DIFFERENTIATION |
6 |
232 |
0.0002033 |
0.00275 |
345 |
MALE SEX DIFFERENTIATION |
5 |
148 |
0.0002078 |
0.002803 |
346 |
SALIVARY GLAND DEVELOPMENT |
3 |
32 |
0.0002144 |
0.002851 |
347 |
POSITIVE REGULATION OF LIPID KINASE ACTIVITY |
3 |
32 |
0.0002144 |
0.002851 |
348 |
POSITIVE REGULATION OF BMP SIGNALING PATHWAY |
3 |
32 |
0.0002144 |
0.002851 |
349 |
PATTERNING OF BLOOD VESSELS |
3 |
32 |
0.0002144 |
0.002851 |
350 |
POSITIVE REGULATION OF DENDRITE MORPHOGENESIS |
3 |
32 |
0.0002144 |
0.002851 |
351 |
POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING |
4 |
81 |
0.0002198 |
0.002913 |
352 |
REGULATION OF ERK1 AND ERK2 CASCADE |
6 |
238 |
0.0002333 |
0.003084 |
353 |
NEURON RECOGNITION |
3 |
33 |
0.0002353 |
0.003093 |
354 |
POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT |
3 |
33 |
0.0002353 |
0.003093 |
355 |
SENSORY ORGAN MORPHOGENESIS |
6 |
239 |
0.0002386 |
0.003128 |
356 |
REGULATION OF LIPASE ACTIVITY |
4 |
83 |
0.0002414 |
0.003155 |
357 |
REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
5 |
153 |
0.0002425 |
0.00316 |
358 |
NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH |
4 |
84 |
0.0002528 |
0.003285 |
359 |
FOREBRAIN NEURON DEVELOPMENT |
3 |
34 |
0.0002574 |
0.003327 |
360 |
RESPONSE TO PROSTAGLANDIN |
3 |
34 |
0.0002574 |
0.003327 |
361 |
SINGLE ORGANISM CELL ADHESION |
8 |
459 |
0.0002637 |
0.003399 |
362 |
EPHRIN RECEPTOR SIGNALING PATHWAY |
4 |
85 |
0.0002645 |
0.0034 |
363 |
NEGATIVE REGULATION OF RESPONSE TO WOUNDING |
5 |
156 |
0.0002653 |
0.003401 |
364 |
WNT SIGNALING PATHWAY |
7 |
351 |
0.0002914 |
0.003725 |
365 |
CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS |
9 |
595 |
0.0003061 |
0.003902 |
366 |
CHEMICAL HOMEOSTASIS |
11 |
874 |
0.0003108 |
0.003951 |
367 |
SEGMENTATION |
4 |
89 |
0.0003155 |
0.004 |
368 |
CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM |
6 |
252 |
0.0003169 |
0.004007 |
369 |
FOREBRAIN DEVELOPMENT |
7 |
357 |
0.0003228 |
0.00407 |
370 |
REGULATION OF CELL MATRIX ADHESION |
4 |
90 |
0.0003293 |
0.004141 |
371 |
GLIAL CELL MIGRATION |
3 |
37 |
0.0003316 |
0.004147 |
372 |
AXON EXTENSION |
3 |
37 |
0.0003316 |
0.004147 |
373 |
CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION |
5 |
166 |
0.0003533 |
0.004407 |
374 |
REGULATION OF APOPTOTIC SIGNALING PATHWAY |
7 |
363 |
0.0003569 |
0.00444 |
375 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
9 |
609 |
0.0003628 |
0.004502 |
376 |
EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS |
4 |
93 |
0.0003731 |
0.004593 |
377 |
NEPHRON EPITHELIUM DEVELOPMENT |
4 |
93 |
0.0003731 |
0.004593 |
378 |
RESPONSE TO HORMONE |
11 |
893 |
0.0003731 |
0.004593 |
379 |
CARBOHYDRATE DERIVATIVE METABOLIC PROCESS |
12 |
1047 |
0.0003799 |
0.004664 |
380 |
APPENDAGE DEVELOPMENT |
5 |
169 |
0.0003835 |
0.004684 |
381 |
LIMB DEVELOPMENT |
5 |
169 |
0.0003835 |
0.004684 |
382 |
SECRETION BY CELL |
8 |
486 |
0.0003866 |
0.004697 |
383 |
REGULATION OF AXON GUIDANCE |
3 |
39 |
0.000388 |
0.004697 |
384 |
TRABECULA MORPHOGENESIS |
3 |
39 |
0.000388 |
0.004697 |
385 |
NEURAL TUBE FORMATION |
4 |
94 |
0.0003887 |
0.004697 |
386 |
NEGATIVE REGULATION OF CELL GROWTH |
5 |
170 |
0.000394 |
0.00475 |
387 |
POSITIVE REGULATION OF SECRETION |
7 |
370 |
0.0004002 |
0.004812 |
388 |
POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE |
5 |
172 |
0.0004157 |
0.004985 |
389 |
REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY |
3 |
40 |
0.0004183 |
0.005004 |
390 |
EPITHELIAL CELL DIFFERENTIATION |
8 |
495 |
0.0004366 |
0.005209 |
391 |
GLIOGENESIS |
5 |
175 |
0.0004499 |
0.005354 |
392 |
NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
4 |
98 |
0.0004554 |
0.005405 |
393 |
INTRACELLULAR SIGNAL TRANSDUCTION |
15 |
1572 |
0.0004729 |
0.005599 |
394 |
CELLULAR MACROMOLECULE LOCALIZATION |
13 |
1234 |
0.0004746 |
0.005605 |
395 |
REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS |
3 |
42 |
0.0004835 |
0.005653 |
396 |
POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS |
3 |
42 |
0.0004835 |
0.005653 |
397 |
POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION |
3 |
42 |
0.0004835 |
0.005653 |
398 |
AUTONOMIC NERVOUS SYSTEM DEVELOPMENT |
3 |
42 |
0.0004835 |
0.005653 |
399 |
VESICLE MEDIATED TRANSPORT |
13 |
1239 |
0.0004932 |
0.005751 |
400 |
NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
4 |
102 |
0.0005298 |
0.006163 |
401 |
REGULATION OF MUSCLE TISSUE DEVELOPMENT |
4 |
103 |
0.0005497 |
0.006363 |
402 |
REGULATION OF MUSCLE ORGAN DEVELOPMENT |
4 |
103 |
0.0005497 |
0.006363 |
403 |
NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION |
3 |
44 |
0.0005549 |
0.006407 |
404 |
REGULATION OF BINDING |
6 |
283 |
0.0005857 |
0.006746 |
405 |
EXOCRINE SYSTEM DEVELOPMENT |
3 |
45 |
0.000593 |
0.006813 |
406 |
TERPENOID METABOLIC PROCESS |
4 |
106 |
0.0006126 |
0.007021 |
407 |
STEM CELL DIFFERENTIATION |
5 |
190 |
0.0006536 |
0.007473 |
408 |
LEUKOCYTE DIFFERENTIATION |
6 |
292 |
0.0006899 |
0.007868 |
409 |
REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY |
2 |
11 |
0.0007075 |
0.00801 |
410 |
LYMPHANGIOGENESIS |
2 |
11 |
0.0007075 |
0.00801 |
411 |
OLFACTORY BULB INTERNEURON DEVELOPMENT |
2 |
11 |
0.0007075 |
0.00801 |
412 |
REGULATION OF LIPID KINASE ACTIVITY |
3 |
48 |
0.0007172 |
0.008071 |
413 |
ANTERIOR POSTERIOR AXIS SPECIFICATION |
3 |
48 |
0.0007172 |
0.008071 |
414 |
CONNECTIVE TISSUE DEVELOPMENT |
5 |
194 |
0.0007181 |
0.008071 |
415 |
REGULATION OF GTPASE ACTIVITY |
9 |
673 |
0.0007447 |
0.00835 |
416 |
LEUKOCYTE ACTIVATION |
7 |
414 |
0.0007788 |
0.008711 |
417 |
LYMPHOCYTE HOMEOSTASIS |
3 |
50 |
0.0008085 |
0.009021 |
418 |
NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY |
5 |
200 |
0.0008235 |
0.009167 |
419 |
NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
4 |
115 |
0.0008318 |
0.00923 |
420 |
NEGATIVE REGULATION OF CELL DEVELOPMENT |
6 |
303 |
0.0008362 |
0.00923 |
421 |
NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE |
2 |
12 |
0.000847 |
0.00923 |
422 |
ROUNDABOUT SIGNALING PATHWAY |
2 |
12 |
0.000847 |
0.00923 |
423 |
AXON EXTENSION INVOLVED IN AXON GUIDANCE |
2 |
12 |
0.000847 |
0.00923 |
424 |
EXIT FROM MITOSIS |
2 |
12 |
0.000847 |
0.00923 |
425 |
CELLULAR RESPONSE TO CHOLESTEROL |
2 |
12 |
0.000847 |
0.00923 |
426 |
POSITIVE REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS |
2 |
12 |
0.000847 |
0.00923 |
427 |
TRACHEA MORPHOGENESIS |
2 |
12 |
0.000847 |
0.00923 |
428 |
PROTEIN SECRETION |
4 |
116 |
0.0008591 |
0.009254 |
429 |
ARTERY MORPHOGENESIS |
3 |
51 |
0.0008567 |
0.009254 |
430 |
RESPONSE TO FIBROBLAST GROWTH FACTOR |
4 |
116 |
0.0008591 |
0.009254 |
431 |
NEGATIVE REGULATION OF CHEMOTAXIS |
3 |
51 |
0.0008567 |
0.009254 |
432 |
CELLULAR RESPONSE TO FATTY ACID |
3 |
51 |
0.0008567 |
0.009254 |
433 |
NEGATIVE REGULATION OF PHOSPHORYLATION |
7 |
422 |
0.000871 |
0.00936 |
434 |
CELLULAR RESPONSE TO HORMONE STIMULUS |
8 |
552 |
0.0008905 |
0.009547 |
435 |
ACTIVATION OF MAPKK ACTIVITY |
3 |
52 |
0.0009068 |
0.0097 |
436 |
MESODERM DEVELOPMENT |
4 |
118 |
0.0009157 |
0.009773 |